In order to clarify the role of 1, 25-dihydroxyvitamin-D [1, 25-(OH)2-D] in calcium stone formation, correlations between l,25-(OH)2-D serum levels and levels of calcium, phosphate and uric acid (UA) in serum or urine and between the l,25-(OH)2-D serum level and age were analyzed in Ill formers of urinary stones (57 Ca stones) and in 44 controls. Furthermore, 1,25-(OH)2-D serum levels as well as levels of Ca, phosphate and UA in serum and urine from formers of different urinary stones and controls were compared. 1,25-(OH)2-D serum levels were determined by a radio-receptor assay based on a calf thymus receptor. l,25-(OH)2-D serum levels correlated positiviely with urinary UA excretion in formers of Ca stones and with urinary Ca excretion in formers of Ca stones and controls. In formers of Ca stones urinary Ca excretion was higher and serum phosphate was lower than in controls. 1,25-(OH)2-D serum levels did not differ. l,25-(OH)2-D serum levels decreased with increasing age in controls, but not in stone formers. Our results show that urinary UA and 1,25-(OH)2-D in serum co-influence Ca stone formation, and they suggest that there is an increased sensitivity to l,25-(OH)2-D in formers of Ca stones.

Keywords:
1, 2 5-Dihydroxy vitamin-D, Uric acid, Calcium, Phosphate, Age, Urinary stones
This content is only available via PDF.
© 1996 S. Karger AG, Basel
1996
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.